Okyo Pharma Limited NPV (OKYO) director dealings

1 director has bought £8k of Okyo Pharma Limited NPV shares across 1 disclosed dealing since March 2026.

Director buys

19 Mar 2026

John Brancaccio — Non-Executive Director

£8,050

Recent news

• OKYO Pharma outlines path to phase 3 NEPTUNE trial of urcosimod for neuropathic corneal pain
• OKYO Pharma Announces Purchase of Shares by Chief Development Officer and Director
• OKYO Pharma files annual report, highlights cash position and Phase 3 trial plans
• OKYO Pharma Stock Rises After Company Outlines Development Pathway For Neuropathic Corneal Pain Drug
• OKYO Pharma to Present Ophthalmology Pipeline Ahead of Phase 3 Urcosimod Trial
• OKYO Pharma Reports New Phase 2 Data Demonstrating Meaningful Improvements in Patient-Reported Quality of Life Outcomes with Urcosimod in Neuropathic Corneal Pain

Browse every company · All director dealings